High energy shock waves (HESW) increase paclitaxel efficacy in a syngeneic model of breast cancer

Technol Cancer Res Treat. 2008 Apr;7(2):117-24. doi: 10.1177/153303460800700204.

Abstract

The combined effect of high energy shock waves (HESW), generated by a piezoelectric device, and paclitaxel on Mat B-III rat breast cancer cells in vitro and in an in vivo animal model is presented. A significant reduction of in vitro Mat B-III cell proliferation versus cells treated with paclitaxel alone was observed with the combined exposure to paclitaxel (0.1, 1, or 10 nM) and HESW (0.22 mJ/mm2, 1000 shots). Moreover earlier induction and enhanced apoptosis occurred in cells subjected to the combined treatment with paclitaxel and HESW at 1 and 10 nM versus paclitaxel alone (p<0.01 and p<0.001, respectively). The percentage of apoptotic cells along with BAD mRNA expression, confirm a significant enhancement of apoptosis in tumor tissues subjected to the combined treatment with paclitaxel (2.5 mg/kg on days 7 and 11) and HESW (0.50 mJ/mm2, 500 shots on day 11) in comparison with paclitaxel alone. In conclusion, these data suggest that HESW enhance paclitaxel cytotoxicity in the Mat B-III syngeneic model of breast cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Apoptosis / drug effects
  • Breast Neoplasms / therapy*
  • Cell Proliferation / drug effects
  • Combined Modality Therapy / methods*
  • Disease Models, Animal
  • Female
  • Gene Expression / drug effects
  • High-Energy Shock Waves / therapeutic use*
  • In Situ Nick-End Labeling
  • Paclitaxel / administration & dosage*
  • Rats
  • Rats, Inbred F344
  • Reverse Transcriptase Polymerase Chain Reaction
  • bcl-Associated Death Protein / biosynthesis

Substances

  • Antineoplastic Agents
  • Bad protein, rat
  • bcl-Associated Death Protein
  • Paclitaxel